Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: A sub-study from the NeoALTTO phase III trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: A sub-study from the NeoALTTO phase III trial

Published:2013-12 Issue:6 Volume:22 Page:1060-1065
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Azim Hatem A.,Rothé Francoise,Aura Claudia Monica,Bavington Malcolm,Maetens Marion,Rouas Ghizlaine,Gebhart Geraldine,Gamez Cristina,Eidtmann Holger,Baselga José,Piccart-Gebhart Martine,Ellis Catherine,Vuylsteke Peter,Cure Hervé,Domont Julien,Ferro Antonella,Toral-Peña Juan Carlos,de Azambuja Evandro,Sotiriou Christos,Di Cosimo Serena,Ignatiadis Michail

Funder

GlaxoSmithKline

Veridex

Roche

European Society for Medical Oncology

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference36 articles.

1. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989

2. HER-2 as a target for breast cancer therapy;Ignatiadis;Clin Cancer Res,2009

3. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer;Piccart-Gebhart;N Engl J Med,2005

4. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer;Romond;N Engl J Med,2005

5. Adjuvant trastuzumab in HER2-positive breast cancer;Slamon;N Engl J Med,2011

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-time assessment of HER2 status in circulating tumor cells of breast cancer patients: Methods of detection and clinical implications;The Journal of Liquid Biopsy;2023-12

2. The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management;Cancers;2023-11-17

3. Latest advances in clinical studies of circulating tumor cells in early and metastatic breast cancer;International Review of Cell and Molecular Biology;2023

4. CTCs in Early Breast Cancer;Circulating Tumor Cells;2023

5. Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer;Cancers;2022-12-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3